India's Piramal buys Bayer's potential Alzheimer drug

April 16 (Reuters) - Indian drugmaker Piramal Healthcare
has agreed to buy a research and development portfolio
from Bayer AG, the company said, in a deal that gives
Piramal rights to florbetaben, a possible Alzheimer treatment.

eastgate towing san diego all city towing seattle denver tow truck